Kevin Marsh

Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations.Clark TG, Diakite M, Auburn S, Campino S, Fry AE, Green A, Richardson A, Small K, Teo YY, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Griffiths MJ, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Rockett KA, Kwiatkowski DP
J Infect Dis, (2009). 199:569-75

Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure.Bejon P, Warimwe G, Mackintosh CL, Mackinnon MJ, Kinyanjui SM, Musyoki JN, Bull PC, Marsh K
Infect Immun, (2009). 77:1917-23

Lack of association of interferon regulatory factor 1 with severe malaria in affected child-parental trio studies across three African populations.Mangano VD, Clark TG, Auburn S, Campino S, Diakite M, Fry AE, Green A, Richardson A, Jallow M, Sisay-Joof F, Pinder M, Griffiths MJ, Newton C, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Modiano D, Kwiatkowski DP, Rockett KA
PLoS One, (2009). 4:e4206

The impact of primary health care on malaria morbidity--defining access by disease burden.O'Meara WP, Noor A, Gatakaa H, Tsofa B, McKenzie FE, Marsh K
Trop Med Int Health, (2009). 14:29-35

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.Bejon P, Lusingu J, Olotu A, Leach A, Lievens M, Vekemans J, Mshamu S, Lang T, Gould J, Dubois MC, Demoitie MA, Stallaert JF, Vansadia P, Carter T, Njuguna P, Awuondo KO, Malabeja A, Abdul O, Gesase S, Mturi N, Drakeley CJ, Savarese B, Villafana T, Ballou WR, Cohen J, Riley EM, Lemnge MM, Marsh K, von Seidlein L
N Engl J Med, (2008). 359:2521-32

Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya.O'Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW, Newton CR, Marsh K
Lancet, (2008). 372:1555-62

Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.McCallum FJ, Persson KE, Mugyenyi CK, Fowkes FJ, Simpson JA, Richards JS, Williams TN, Marsh K, Beeson JG
PLoS One, (2008). 3:e3571

Association of the GNAS locus with severe malaria.Auburn S, Diakite M, Fry AE, Ghansah A, Campino S, Richardson A, Jallow M, Sisay-Joof F, Pinder M, Griffiths MJ, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Koram KA, Oduro AR, Rogers WO, Rockett KA, Haldar K, Kwiatkowski DP
Hum Genet, (2008). 124:499-506

Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1.Mackintosh CL, Christodoulou Z, Mwangi TW, Kortok M, Pinches R, Williams TN, Marsh K, Newbold CI
Malar J, (2008). 7:155

Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity.O'Meara WP, Mwangi TW, Williams TN, McKenzie FE, Snow RW, Marsh K
Am J Trop Med Hyg, (2008). 79:185-91

Immunity to malaria: more questions than answers.Langhorne J, Ndungu FM, Sponaas AM, Marsh K
Nat Immunol, (2008). 9:725-32

Failure to respond to the surface of Plasmodium falciparum infected erythrocytes predicts susceptibility to clinical malaria amongst African children.Mackintosh CL, Mwangi T, Kinyanjui SM, Mosobo M, Pinches R, Williams TN, Newbold CI, Marsh K
Int J Parasitol, (2008). 38:1445-54

Variation in the ICAM1 gene is not associated with severe malaria phenotypes.Fry AE, Auburn S, Diakite M, Green A, Richardson A, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Griffiths MJ, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Rockett KA, Kwiatkowski DP
Genes Immun, (2008). 9:462-9

Evidence for over-dispersion in the distribution of clinical malaria episodes in children.Mwangi TW, Fegan G, Williams TN, Kinyanjui SM, Snow RW, Marsh K
PLoS One, (2008). 3:e2196

Plasmodium falciparum STEVOR proteins are highly expressed in patient isolates and located in the surface membranes of infected red blood cells and the apical tips of merozoites.Blythe JE, Yam XY, Kuss C, Bozdech Z, Holder AA, Marsh K, Langhorne J, Preiser PR
Infect Immun, (2008). 76:3329-36

Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.Todryk SM, Bejon P, Mwangi T, Plebanski M, Urban B, Marsh K, Hill AV, Flanagan KL
PLoS One, (2008). 3:e2027

Plasmodium falciparum antigenic variation. Mapping mosaic var gene sequences onto a network of shared, highly polymorphic sequence blocks.Bull PC, Buckee CO, Kyes S, Kortok MM, Thathy V, Guyah B, Stoute JA, Newbold CI, Marsh K
Mol Microbiol, (2008). 68:1519-34

Promoting the social value of research in Kenya: examining the practical aspects of collaborative partnerships using an ethical framework.Lairumbi GM, Molyneux S, Snow RW, Marsh K, Peshu N, English M
Soc Sci Med, (2008). 67:734-47

Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya.Agak GW, Bejon P, Fegan G, Gicheru N, Villard V, Kajava AV, Marsh K, Corradin G
Vaccine, (2008). 26:1963-71

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.Osier FH, Fegan G, Polley SD, Murungi L, Verra F, Tetteh KK, Lowe B, Mwangi T, Bull PC, Thomas AW, Cavanagh DR, McBride JS, Lanar DE, Mackinnon MJ, Conway DJ, Marsh K
Infect Immun, (2008). 76:2240-8